Airway goblet-cell mucus secretion

A mucus hypersecretory phenotype is a dominant characteristic of chronic airways diseases such as chronic bronchitis and asthma. This phenotype develops following chronic exposure of the respiratory tract to particulate matter, allergens, irritants and/or pathogens. The associated increase in the mu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Trends in Pharmacological Sciences 2001, Vol.22 (1), p.39-45
1. Verfasser: Jackson, Alan D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 45
container_issue 1
container_start_page 39
container_title Trends in Pharmacological Sciences
container_volume 22
creator Jackson, Alan D
description A mucus hypersecretory phenotype is a dominant characteristic of chronic airways diseases such as chronic bronchitis and asthma. This phenotype develops following chronic exposure of the respiratory tract to particulate matter, allergens, irritants and/or pathogens. The associated increase in the mucus-producing potential of the respiratory epithelium represents an innate host response that can be modulated by elements of the adaptive host response. Although elevation of mucus production is designed to protect the airways, increasing evidence suggests that in excess it can be detrimental to health. Considerable progress has been made over the past five years in understanding the mechanisms involved in the development and regulation of the hypersecretory phenotype. This progress has set the stage for the development of successful dedicated mucomodulatory strategies to counter the negative impact of excess mucus production in respiratory disease.
doi_str_mv 10.1016/S0165-6147(00)01600-X
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70630079</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S016561470001600X</els_id><sourcerecordid>70630079</sourcerecordid><originalsourceid>FETCH-LOGICAL-c361t-5d541728a5aef9c7e7e052837fd42b370dddadfca42dc1873eda37e2f07e41903</originalsourceid><addsrcrecordid>eNqFkE1LAzEQhoMotlZ_grJ4ED1EJ5vNpj1JKX5BwYMKvYU0mZXIftRkV-m_N9sWPXqZYZhn5p15CTllcM2A5TcvMQias0xeAlzFAoAu9siQjSWnXHKxT4a_yIAchfABAJyn7JAMGIudXLIhOZ86_63XyXuzLLGlBssyqTrThSSg8di6pj4mB4UuA57s8oi83d-9zh7p_PnhaTadU8Nz1lJhRcZkOtZCYzExEiWCSMdcFjZLl1yCtVbbwugstaa_Eq3mEtMCJGZsAnxELrZ7V7757DC0qnKhP0jX2HRBScg5gJxEUGxB45sQPBZq5V2l_VoxUL05amOO6j9XAGpjjlrEubOdQLes0P5N7dyIwO0WwPjml0OvgnFYG7TOo2mVbdw_Ej-eLHL7</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70630079</pqid></control><display><type>article</type><title>Airway goblet-cell mucus secretion</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Jackson, Alan D</creator><creatorcontrib>Jackson, Alan D</creatorcontrib><description>A mucus hypersecretory phenotype is a dominant characteristic of chronic airways diseases such as chronic bronchitis and asthma. This phenotype develops following chronic exposure of the respiratory tract to particulate matter, allergens, irritants and/or pathogens. The associated increase in the mucus-producing potential of the respiratory epithelium represents an innate host response that can be modulated by elements of the adaptive host response. Although elevation of mucus production is designed to protect the airways, increasing evidence suggests that in excess it can be detrimental to health. Considerable progress has been made over the past five years in understanding the mechanisms involved in the development and regulation of the hypersecretory phenotype. This progress has set the stage for the development of successful dedicated mucomodulatory strategies to counter the negative impact of excess mucus production in respiratory disease.</description><identifier>ISSN: 0165-6147</identifier><identifier>EISSN: 1873-3735</identifier><identifier>DOI: 10.1016/S0165-6147(00)01600-X</identifier><identifier>PMID: 11165671</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Animals ; Asthma ; Chronic bronchitis ; Goblet Cells - drug effects ; Goblet Cells - secretion ; Humans ; Metaplasia ; Mucus ; Mucus - secretion ; Preclinical models ; Secretion ; Secretory Rate - drug effects</subject><ispartof>Trends in Pharmacological Sciences, 2001, Vol.22 (1), p.39-45</ispartof><rights>2001 Elsevier Science Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c361t-5d541728a5aef9c7e7e052837fd42b370dddadfca42dc1873eda37e2f07e41903</citedby><cites>FETCH-LOGICAL-c361t-5d541728a5aef9c7e7e052837fd42b370dddadfca42dc1873eda37e2f07e41903</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0165-6147(00)01600-X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>313,314,780,784,792,3550,4054,27922,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11165671$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jackson, Alan D</creatorcontrib><title>Airway goblet-cell mucus secretion</title><title>Trends in Pharmacological Sciences</title><addtitle>Trends Pharmacol Sci</addtitle><description>A mucus hypersecretory phenotype is a dominant characteristic of chronic airways diseases such as chronic bronchitis and asthma. This phenotype develops following chronic exposure of the respiratory tract to particulate matter, allergens, irritants and/or pathogens. The associated increase in the mucus-producing potential of the respiratory epithelium represents an innate host response that can be modulated by elements of the adaptive host response. Although elevation of mucus production is designed to protect the airways, increasing evidence suggests that in excess it can be detrimental to health. Considerable progress has been made over the past five years in understanding the mechanisms involved in the development and regulation of the hypersecretory phenotype. This progress has set the stage for the development of successful dedicated mucomodulatory strategies to counter the negative impact of excess mucus production in respiratory disease.</description><subject>Animals</subject><subject>Asthma</subject><subject>Chronic bronchitis</subject><subject>Goblet Cells - drug effects</subject><subject>Goblet Cells - secretion</subject><subject>Humans</subject><subject>Metaplasia</subject><subject>Mucus</subject><subject>Mucus - secretion</subject><subject>Preclinical models</subject><subject>Secretion</subject><subject>Secretory Rate - drug effects</subject><issn>0165-6147</issn><issn>1873-3735</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1LAzEQhoMotlZ_grJ4ED1EJ5vNpj1JKX5BwYMKvYU0mZXIftRkV-m_N9sWPXqZYZhn5p15CTllcM2A5TcvMQias0xeAlzFAoAu9siQjSWnXHKxT4a_yIAchfABAJyn7JAMGIudXLIhOZ86_63XyXuzLLGlBssyqTrThSSg8di6pj4mB4UuA57s8oi83d-9zh7p_PnhaTadU8Nz1lJhRcZkOtZCYzExEiWCSMdcFjZLl1yCtVbbwugstaa_Eq3mEtMCJGZsAnxELrZ7V7757DC0qnKhP0jX2HRBScg5gJxEUGxB45sQPBZq5V2l_VoxUL05amOO6j9XAGpjjlrEubOdQLes0P5N7dyIwO0WwPjml0OvgnFYG7TOo2mVbdw_Ej-eLHL7</recordid><startdate>2001</startdate><enddate>2001</enddate><creator>Jackson, Alan D</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2001</creationdate><title>Airway goblet-cell mucus secretion</title><author>Jackson, Alan D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c361t-5d541728a5aef9c7e7e052837fd42b370dddadfca42dc1873eda37e2f07e41903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Animals</topic><topic>Asthma</topic><topic>Chronic bronchitis</topic><topic>Goblet Cells - drug effects</topic><topic>Goblet Cells - secretion</topic><topic>Humans</topic><topic>Metaplasia</topic><topic>Mucus</topic><topic>Mucus - secretion</topic><topic>Preclinical models</topic><topic>Secretion</topic><topic>Secretory Rate - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jackson, Alan D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Trends in Pharmacological Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jackson, Alan D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Airway goblet-cell mucus secretion</atitle><jtitle>Trends in Pharmacological Sciences</jtitle><addtitle>Trends Pharmacol Sci</addtitle><date>2001</date><risdate>2001</risdate><volume>22</volume><issue>1</issue><spage>39</spage><epage>45</epage><pages>39-45</pages><issn>0165-6147</issn><eissn>1873-3735</eissn><abstract>A mucus hypersecretory phenotype is a dominant characteristic of chronic airways diseases such as chronic bronchitis and asthma. This phenotype develops following chronic exposure of the respiratory tract to particulate matter, allergens, irritants and/or pathogens. The associated increase in the mucus-producing potential of the respiratory epithelium represents an innate host response that can be modulated by elements of the adaptive host response. Although elevation of mucus production is designed to protect the airways, increasing evidence suggests that in excess it can be detrimental to health. Considerable progress has been made over the past five years in understanding the mechanisms involved in the development and regulation of the hypersecretory phenotype. This progress has set the stage for the development of successful dedicated mucomodulatory strategies to counter the negative impact of excess mucus production in respiratory disease.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>11165671</pmid><doi>10.1016/S0165-6147(00)01600-X</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0165-6147
ispartof Trends in Pharmacological Sciences, 2001, Vol.22 (1), p.39-45
issn 0165-6147
1873-3735
language eng
recordid cdi_proquest_miscellaneous_70630079
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Animals
Asthma
Chronic bronchitis
Goblet Cells - drug effects
Goblet Cells - secretion
Humans
Metaplasia
Mucus
Mucus - secretion
Preclinical models
Secretion
Secretory Rate - drug effects
title Airway goblet-cell mucus secretion
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T11%3A18%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Airway%20goblet-cell%20mucus%20secretion&rft.jtitle=Trends%20in%20Pharmacological%20Sciences&rft.au=Jackson,%20Alan%20D&rft.date=2001&rft.volume=22&rft.issue=1&rft.spage=39&rft.epage=45&rft.pages=39-45&rft.issn=0165-6147&rft.eissn=1873-3735&rft_id=info:doi/10.1016/S0165-6147(00)01600-X&rft_dat=%3Cproquest_cross%3E70630079%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70630079&rft_id=info:pmid/11165671&rft_els_id=S016561470001600X&rfr_iscdi=true